PharmaEngine, Inc. - Laporan Laba Rugi (TTM)

PharmaEngine, Inc.
TW ˙ TPEX ˙ TW0004162003
NT$ 97.40 ↓ -0.90 (-0.92%)
2024-10-25
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi PharmaEngine, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 344 1,056 1,088 1,156 1,237 655 713 722 700 654 649 648 739 768 764 860 832 2,523 2,546 2,481
Change (%) 206.56 3.02 6.26 7.05 -47.08 8.93 1.21 -3.08 -6.48 -0.89 -0.13 14.06 3.91 -0.50 12.55 -3.22 203.31 0.91 -2.56
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 35 37 37 38 39 37 40 42 45 50 52 52 50 49 46 45 46 48 49 48
Change (%) 5.38 0.59 2.17 1.21 -4.27 6.61 5.72 7.74 10.40 4.00 0.62 -3.58 -2.88 -5.30 -2.32 2.36 3.54 2.80 -1.50
% of Revenue 10.26 3.53 3.44 3.31 3.13 5.66 5.54 5.79 6.43 7.59 7.97 8.03 6.79 6.34 6.04 5.24 5.54 1.89 1.93 1.95
Gross Operating Profit 309 1,019 1,050 1,118 1,199 618 674 680 655 605 597 596 689 719 718 815 786 2,476 2,497 2,433
Change (%) 229.55 3.11 6.41 7.25 -48.47 9.07 0.95 -3.75 -7.64 -1.29 -0.19 15.60 4.40 -0.18 13.50 -3.53 215.03 0.87 -2.58
% of Revenue 89.74 96.47 96.56 96.69 96.87 94.34 94.46 94.21 93.57 92.41 92.03 91.97 93.21 93.66 93.96 94.76 94.46 98.11 98.07 98.05
SG&A 95 113 119 128 133 118 119 124 135 140 146 146 136 132 127 127 134 155 157 154
Change (%) 19.78 5.37 6.77 4.48 -11.30 0.96 3.89 8.86 3.80 4.58 -0.63 -6.67 -3.19 -3.40 0.33 5.38 15.68 0.78 -1.91
% of Revenue 27.47 10.73 10.98 11.03 10.77 18.05 16.73 17.17 19.28 21.40 22.58 22.47 18.39 17.13 16.63 14.83 16.14 6.16 6.15 6.19
R&D 98 96 118 119 136 137 110 108 151 182 203 247 291 310 327 333 259 267 266 250
Change (%) -2.74 23.58 0.67 14.40 0.47 -19.84 -1.22 39.70 20.12 11.73 21.44 17.99 6.56 5.45 1.90 -22.39 3.20 -0.39 -5.88
% of Revenue 28.57 9.07 10.87 10.30 11.01 20.90 15.38 15.01 21.64 27.79 31.33 38.10 39.41 40.42 42.84 38.78 31.10 10.58 10.45 10.09
OpEx 228 246 275 285 308 292 269 274 331 372 401 444 477 490 500 506 439 470 472 452
Change (%) 7.85 11.73 3.52 8.19 -5.21 -8.07 2.07 20.88 12.15 8.00 10.71 7.39 2.79 2.01 1.11 -13.19 7.05 0.32 -4.11
% of Revenue 66.30 23.32 25.30 24.64 24.91 44.61 37.65 37.97 47.36 56.79 61.89 68.60 64.59 63.89 65.51 58.85 52.79 18.63 18.52 18.23
Operating Income 116 810 813 871 929 363 445 448 368 283 247 203 262 277 263 354 393 2,053 2,075 2,029
Change (%) 597.46 0.37 7.19 6.67 -60.97 22.63 0.69 -17.75 -23.24 -12.57 -17.72 28.63 5.94 -4.95 34.26 11.03 422.77 1.04 -2.21
% of Revenue 33.70 76.68 74.70 75.36 75.09 55.39 62.35 62.03 52.64 43.21 38.11 31.40 35.41 36.11 34.49 41.15 47.21 81.37 81.48 81.77
Interest Expense -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Change (%) 7.00 -22.35 -11.34 -13.44 -19.70 -22.17 -28.48 -37.29 4.05 87.01 46.53 31.75 11.51 -10.65 -11.19 -13.41 -15.02 -17.68 -18.79
% of Revenue -0.12 -0.04 -0.03 -0.03 -0.02 -0.03 -0.02 -0.02 -0.01 -0.01 -0.02 -0.03 -0.04 -0.04 -0.04 -0.03 -0.03 -0.01 -0.01 -0.00
Net Income 45 604 631 782 837 426 447 362 377 319 303 298 291 275 275 359 370 1,751 1,772 1,631
Change (%) 1,253.89 4.44 23.97 7.00 -49.11 5.01 -19.00 3.95 -15.37 -4.91 -1.83 -2.25 -5.58 0.13 30.46 3.17 373.07 1.18 -7.96
% of Revenue 12.96 57.22 58.01 67.68 67.65 65.06 62.72 50.20 53.84 48.72 46.74 45.94 39.37 35.78 36.00 41.73 44.49 69.39 69.58 65.72

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista